# Nodal Staging in Breast Cancer With MRL

> **NCT01609920** · NA · TERMINATED · sponsor: **Maastricht University Medical Center** · enrollment: 97 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** Gadofosveset enhanced MRL of axillary lymph nodes

## Key facts

- **NCT ID:** NCT01609920
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 97 (ACTUAL)
- **Why stopped:** Manufacturer recently halted production of gadofosveset.
- **Last updated:** 2016-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01609920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01609920, "Nodal Staging in Breast Cancer With MRL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01609920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*